Skip to content
StockMarketAgent
Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0QB4 stock hub

LON/0QB4 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0QB4is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
312M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0QB4
In the news

Latest news · LON/0QB4

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9
P25 12.9P50 16.9P75 23.5
Trailing P/E23.3
P25 15.9P50 22.9P75 35.8
ROE3
P25 -54.2P50 2.1P75 13.7
ROIC3.8
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0QB4 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
EUR
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
UK
Employees
868
Employees Change
47%
Employees Change Percent
4.94
Enterprise value
EUR 413.5M
Exchange
London Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Medical - Equipment & Services
Isin
DE000A1MMCC8
Last refreshed
2026-05-10
Market cap
EUR 312M
Price
EUR 14.96
Price currency
EUR
Rev Per Employee
2,089,290.89x
Sector
Healthcare
Sic
5122
Symbol
lon/0QB4
Website
https://www.medios.ag

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.3%
EV Earnings
30.85x
EV/EBIT
11.1x
EV/EBITDA
5.91x
EV/FCF
10.26x
EV/Sales
0.23x
FCF yield
12.92%
Forward P/E
12.93x
P/B ratio
0.7x
P/E ratio
23.28x
P/S ratio
0.17x
PE Ratio10 Y
52.68x
PE Ratio3 Y
22.52x
PE Ratio5 Y
41.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
2.08%
EBITDA Margin
3.64%
FCF margin
2.22%
Gross margin
9.5%
Gross Profit
EUR 172.2M
Gross Profit Growth
31.5%
Gross Profit Growth Q
9.88%
Gross Profit Growth3 Y
23.1%
Gross Profit Growth5 Y
39.49%
Net Income
EUR 13.4M
Net Income Growth
22.45%
Net Income Growth Years
1%
Net Income Growth3 Y
-5.71%
Net Income Growth5 Y
22.7%
Pretax Margin
1.34%
Profit Margin
0.74%
Profit Per Employee
EUR 15,442
Profitable Years
9
ROA
2.94
Roa5y
2.99
ROCE
5.98
ROE
3
Roe5y
3.36
ROIC
3.79
Roic5y
4.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr1y
20.86%
Cagr3y
-6.53%
Cagr5y
-15.92%
EPS Growth
20.44
EPS Growth Years
1
EPS Growth3 Y
-7.47
EPS Growth5 Y
11.75
FCF Growth
-32.96%
FCF Growth3 Y
12.23%
OCF Growth
-29.04%
OCF Growth3 Y
12.08%
Revenue Growth
10.4x
Revenue Growth Q
13.74x
Revenue Growth Quarters
36x
Revenue Growth Years
10x
Revenue Growth3 Y
8.85x
Revenue Growth5 Y
27.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 2.26
Assets
EUR 787.8M
Cash
EUR 72.1M
Current Assets
EUR 297.3M
Current Liabilities
EUR 156.8M
Debt
EUR 174.6M
Debt EBITDA
EUR 2.47
Debt Equity
EUR 0.39
Debt FCF
EUR 4.33
Equity
EUR 448.6M
Interest Coverage
2.26
Liabilities
EUR 339.2M
Long Term Assets
EUR 490.5M
Long Term Liabilities
EUR 182.4M
Net Cash
EUR -102.5M
Net Cash By Market Cap
EUR -32.86
Net Debt EBITDA
EUR 1.55
Net Debt Equity
EUR 0.23
Net Debt FCF
EUR 2.54
Tangible Book Value
EUR 26.8M
Tangible Book Value Per Share
EUR 1.09
WACC
9.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.9
Inventory Turnover
20.26
Net Working Capital
EUR 95.7M
Quick ratio
1.35
Working Capital
EUR 141.6M
Working Capital Turnover
EUR 10.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
20.84%
200-day SMA
14.13
3Y total return
-18.34%
50-day SMA
14
50-day SMA vs 200-day SMA
50under200
5Y total return
-57.99%
All Time High
41.4
All Time High Change
-63.86%
All Time High Date
2021-11-11
All Time Low
10.2
All Time Low Change
46.67%
All Time Low Date
2025-04-07
ATR
0.36
Beta
1.31
Ch YTD
2.75
High
15
High52
17.44
High52 Date
2026-02-19
High52ch
-14.22%
Low
14.88
Low52
11.28
Low52 Date
2025-06-17
Low52ch
32.62%
Ma50ch
6.85%
Price vs 200-day SMA
5.87%
RSI
69.27
RSI Monthly
50.17
RSI Weekly
53.3
Sharpe ratio
0.5x
Sortino ratio
0.91
Total Return
-1.1%
Tr YTD
2.75
Tr1m
19.68%
Tr1w
9.68%
Tr3m
-7.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 37.6M
Operating Income Growth
25.69
Operating Income Growth Q
7.62
Operating Income Growth3 Y
15.47
Operating Income Growth5 Y
33.07
Operating margin
2.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
8,330,843%
Net Borrowing
-43,269,750.1
Shares Insiders
5.38%
Shares Institutions
30.92%
Shares Qo Q
-0.73%
Shares Yo Y
1.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
EUR 40.3M
Average Volume
4,886.35x
Bv Per Share
18.31
CAPEX
EUR -5.3M
Ch1m
19.68
Ch1w
9.68
Ch1y
20.84
Ch3m
-7.59
Ch3y
-18.34
Ch5y
-57.99
Ch6m
20.94
Change
3.74%
Change From Open
-0.27
Close
14.42
Days Gap
4.02
Depreciation Amortization
28,103,149.5
Dollar Volume
1,466.1
Earnings Date
2026-05-12
EBIT
EUR 37.6M
EBITDA
EUR 66M
EPS
EUR 0.53
F Score
6
FCF
EUR 40.3M
FCF EV Yield
9.75x
Financing CF
-63,363,061
Fiscal Year End
December
Founded
2,016
Goodwill
311,922,641.3
Graham Number
17.63558
Graham Upside
17.88
Income Tax
EUR 10.9M
Investing CF
-3,506,939
Is Primary Listing
0
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Lynch Fair Value
EUR 14.59
Lynch Upside
-2.49
Ma150
14.31
Ma150ch
4.56%
Ma20
13.61
Ma20ch
9.94%
Net CF
-21,268,451
Next Earnings Date
2026-05-12
Open
15
P FCF Ratio
7.74
P OCF Ratio
6.84
Position In Range
66.67
Ppne
61,799,593.8
Price Date
2026-05-08
Price EBITDA
EUR 4.73
Ptbv Ratio
11.65
Relative Volume
0.02x
Revenue
1,813,504,489x
Tax By Revenue
0.6x
Tax Rate
44.92%
Tr6m
20.94%
Volume
98
Z Score
3.33
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0QB4 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QB4 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+20.8%
S&P 500 1Y: n/a
3Y total return
-18.3%
S&P 500 3Y: n/a
5Y total return
-58.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0QB4?

Insider, institutional, and short-interest positioning.

Institutional ownership
+30.9%
Share of float held by funds and institutions
Insider ownership
+5.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.1%
Negative means the company is buying back shares.
Technical

LON/0QB4 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
69.3
Neutral momentum band
Price vs 200-day MA
+5.9%
50/200-day relationship not available
Beta (5Y)
1.31
More volatile than the market
Sharpe ratio
0.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0QB4

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QB4 stock rating?

lon/0QB4 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QB4 analysis?

The full report lives at /stocks/lon/0QB4/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QB4?

The latest report frames lon/0QB4 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QB4 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0QB4 stock profile: metrics, valuation and analysis | وكيل سوق الأسهم بالذكاء الاصطناعي